Search

Author/Creator Higgs, Richard E

1. 185 Baricitinib-associated changes in type I interferon gene signature during a 24-week phase 2 clinical SLE trial. (April 2019)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle; Smolen, Josef S; Dow, Ernst R; Higgs, Richard E; Benschop, Robert J; Abel, Adam; Silk, Maria E; Bono, Stephanie de; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 6(2019)supplement 1
Page Start:
A141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load. (28th October 2021)

Authors:
Dougan, Michael; Azizad, Masoud; Mocherla, Bharat; Gottlieb, Robert L; Chen, Peter; Hebert, Corey; Perry, Russell; Boscia, Joseph; Heller, Barry; Morris, Jason; Crystal, Chad; Igbinadolor, Awawu; Huhn, Gregory; Cardona, Jose; Shawa, Imad; Kumar, Princy; Blomkalns, Andra; Adams, Andrew C; Van Naar...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 1(2022)
Page Start:
e440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗